A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants
Status:
Completed
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate effect of single and repeated doses of darunavir
(DRV) in combination with cobicistat (DRV/COBI) and with ritonavir (DRV+rtv) on the
pharmacokinetics of single dose dabigatran etexilate (measured in plasma as free and total
dabigatran) when co-administered in healthy participants.